The survey, performed by Silicon Valley Bank, polled 122 founders, execs and investors in health care technology companies about the biggest challenges, most promising technology and biggest growth sectors in the industry for the coming year.
The most promising technology for the sector was utilization of big data, with 46% of of responders ranking it number 1, closely followed by artificial intelligence, with 35%.
Consumer, patient and client adoption was the biggest challenge reported by polled individual for the industry, with 37% placing it at the top. Thirty four percent reported that regulation was the largest challenge for the sector.
Gaining traction with existing technology was reported as having the greatest impact on investments in the sector over the next year, while the presidential election was considered the least influential factor for investment, with only 7% of responders placing it first.
The biggest growth sector in the industry was reported to be healthcare delivery and IT, while mobile health apps, wearables and consumer products ranking much lower. Venture capital is still seen as the greatest funding opportunity, with 61% of responders ranking it first.
“Big data has been integral to our work at Celmatix. It has empowered physicians to be able to counsel women about their chances of having a baby, based on their relevant personal metrics, and not just their age. It’s an exciting time to be in a field where the pace of innovation continues to increase as both physicians and patients realize the potential of big data and personalized medicine,” Celmatix CEO Dr. Piraye Beim said in prepared remarks.